EU Scaleup Fund leads $100m Tandem Health raise
THE SO WHAT
The EU Scaleup Fund leading a $100M round into Tandem Health shows Brussels is willing to write late-stage checks to keep healthtech champions onshore. European founders in regulated sectors should factor public capital into their scaling options, not just US growth equity.
READ THE SOURCE
MORE FROM THE WIRE
Startups & VentureICBC, HSBC Among Major Lenders on $30 Billion ByteDance Loan
A $29.6B multi-bank loan to ByteDance signals that large-scale consumer platforms with AI exposure can still command deep, dollar-denominated credit even under geopolitical scrutiny. If you’re a later-stage platform, expect lenders to underwrite not just cash flow but also your regulatory and data-sovereignty posture.
Startups & VentureExclusive: LocalGlobe, Cherry back Resolutiion with $10m
Early-stage capital is still flowing into niche vertical plays—$10m at seed/Series A scale is a bet that this category can compound into a platform, not just a feature. If you’re building in the same wedge, assume faster follow-on competition and prioritize defensible data or distribution over incremental UX.
Startups & VentureThe companies that shot up Sifted’s DACH & CEE leaderboard
Leaderboards like this are a proxy for where talent and follow-on capital are concentrating in DACH & CEE. If you’re hiring or expanding in-region, treat the top movers as both recruiting targets and competitive benchmarks for comp, pace, and product ambition.
Startups & Venture‘We are in a land grab moment’: Lexroom CEO on the race to buy up legaltechs
A declared “land grab” in legaltech means roll-ups and platform plays are accelerating before AI-native workflows fully settle. Founders in adjacent B2B services should expect similar consolidation pressure—optimize now for either being an acquirer with real balance sheet or a clearly accretive target.